Outcomes of pregnancy in autoimmune hepatitis: A population‐based study
Connie W. Wang, Joshua Grab, Michele M. Tana, Roxanna A. Irani, Monika Sarkar – 27 August 2021
Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant
Melissa Merkel, Christina Schneider, Robin Greinert, Alexander Zipprich, Cristina Ripoll, Frank Lammert, Matthias C. Reichert – 27 August 2021 – Complications of cirrhosis and portal hypertension (PH) can be reduced by statin therapy. The common loss‐of‐function variant p.V174A in the solute carrier organic anion transporter gene 1B1 (SLCO1B1) gene encoding the organic anion transporting polypeptide 1B1 results in decreased hepatic uptake of statins.
Letter to the Editor: Toxin‐induced graft injury following liver transplantation for yellow phosphorus poisoning
Joy Varghese, Selvakumar Malleswaran, Karattupaayam Mouleeswaran – 27 August 2021
Transcriptomic Cross‐Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice
Christian H. Holland, Ricardo O. Ramirez Flores, Maiju Myllys, Reham Hassan, Karolina Edlund, Ute Hofmann, Rosemarie Marchan, Cristina Cadenas, Jörg Reinders, Stefan Hoehme, Abdel‐latif Seddek, Steven Dooley, Verena Keitel, Patricio Godoy, Brigitte Begher‐Tibbe, Christian Trautwein, Christian Rupp, Sebastian Mueller, Thomas Longerich, Jan G. Hengstler, Julio Saez‐Rodriguez, Ahmed Ghallab – 27 August 2021 – Mouse models are frequently used to study chronic liver diseases (CLDs).
S‐adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells
Komal Ramani, Aaron E. Robinson, Joshua Berlind, Wei Fan, Aushinie Abeynayake, Aleksandra Binek, Lucía Barbier‐Torres, Mazen Noureddin, Nicholas N. Nissen, Zehra Yildirim, Ebru Erbay, José M. Mato, Jennifer E. Van Eyk, Shelly C. Lu – 26 August 2021
Hepatic Manifestations of Mendelian Disorders of Cholesterol Biosynthesis and Cellular Metabolism
Alanna Strong, Rebecca Ganetzky, Daniel J. Rader – 26 August 2021
The Liver and COVID‐19 in Mexico
José María Remes‐Troche, José Antonio Velarde‐Ruiz Velasco – 26 August 2021
Hepatic Manifestations of Mendelian Disorders of Cholesterol Biosynthesis and Cellular Metabolism
Alanna Strong, Rebecca Ganetzky, Daniel J. Rader – 26 August 2021
Hepatic Manifestations of Mendelian Disorders of Cholesterol Biosynthesis and Cellular Metabolism
Alanna Strong, Rebecca Ganetzky, Daniel J. Rader – 26 August 2021
Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Nataliya Rohr‐Udilova, Kaoru Tsuchiya, Gerald Timelthaler, Martina Salzmann, Tobias Meischl, Katharina Wöran, Judith Stift, Merima Herac, Rolf Schulte‐Hermann, Markus Peck‐Radosavljevic, Wolfgang Sieghart, Robert Eferl, Erika Jensen‐Jarolim, Michael Trauner, Matthias Pinter – 26 August 2021 – Tumor‐infiltrating immune cells are relevant prognostic and immunotherapeutic targets in hepatocellular carcinoma (HCC). Mast cells play a key role in allergic response but may also be involved in anticancer immunity.